ENLV icon

Enlivex Therapeutics
ENLV

10 hedge funds and large institutions have $5.53M invested in Enlivex Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.82M
2
+$28.1K

Top Sellers

1
-$325K
2
-$217K
3
-$108K
4
OC
Oppenheimer & Co
New York
-$40.7K
5
UBS Group
UBS Group
Switzerland
-$12.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.82M
2
$1.78M
3
$625K
4
$155K
5
$86K
6
$54K
7
$4K
8
$2K
9
$1K
10
–
11
–
12
–
13
–